☆ 4.5 Article

Microscopic Polyangiitis Following mRNA COVID-19 Vaccination: A Case Report

JOURNAL OF KOREAN MEDICAL SCIENCE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Dermatology

Comparison of constitutional and dermatologic side effects between COVID-19 and noneCOVID-19 vaccines: Review of a publicly available database of vaccine side effects

Stephanie R. Cohen et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

添加到收藏夹

Review Microbiology

Infectious disease in an era of global change

Rachel E. Baker et al.

Summary: Global changes such as climate change, urbanization, and global travel and trade have impacted the emergence and spread of infectious diseases. Recent decades have seen a wave of severe infectious disease outbreaks, including COVID-19 and Zika virus disease, which have had devastating effects worldwide.

NATURE REVIEWS MICROBIOLOGY (2022)

添加到收藏夹

Article Urology & Nephrology

MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination

Shota Obata et al.

Summary: COVID-19 vaccines may increase the risk of immune-mediated diseases, as shown in a case of ANCA-associated vasculitis following vaccination with the BNT162b2 vaccine. The causal relationship between the vaccine and vasculitis is uncertain, but environmental and genetic factors may have played a role in the development of the disease, with the vaccine potentially triggering a chain reaction.

CLINICAL KIDNEY JOURNAL (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

Efficiency decreases

Halane Vaillant-Roussel et al.

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)

添加到收藏夹

Review Medicine, General & Internal

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

Daniel R. Feikin et al.

Summary: This study systematically reviewed the duration of protection provided by COVID-19 vaccines against various clinical outcomes. The findings indicate that the effectiveness or efficacy of the vaccines decreased from 1 to 6 months after full vaccination, but remained high against severe disease. Evaluating the effectiveness or efficacy of vaccines beyond 6 months is crucial for updating vaccine policies.

LANCET (2022)

添加到收藏夹

Editorial Material Urology & Nephrology

Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine

Geoffrey K. Dube et al.

KIDNEY INTERNATIONAL REPORTS (2021)

添加到收藏夹

Article Urology & Nephrology

ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine

Muhammad Tariq Shakoor et al.

Summary: Severe acute respiratory syndrome coronavirus 2 (SAR S-CoV-2) is still spreading worldwide, driving the largest vaccination campaign in human history. Although the vaccines have been found to be safe and effective, rare side effects continue to arise. A case of new-onset renal-limited ANCA-associated vasculitis (AAV) in a 78-year-old woman post Pfizer-BioNTech COVID-19 vaccination highlights the need for ongoing surveillance for similar complications.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

添加到收藏夹

Article Immunology

Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination

Samy Hakroush et al.

Summary: Continuous monitoring of COVID-19 vaccine safety is crucial as vaccination programs expand worldwide, particularly in detecting rare adverse events associated with vaccination.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Letter Urology & Nephrology

ANCA glomerulonephritis after the Moderna COVID-19 vaccination

Arjun Sekar et al.

KIDNEY INTERNATIONAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older

Youn Young Choi et al.

Summary: The study examined the safety of the COVID-19 vaccine for adults aged 75 and older who received two doses at a vaccination center in South Korea. The frequency of acute adverse reactions within 15-30 minutes after injection was 8.5 cases per 1,000 doses, with most reactions not requiring special treatment.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

添加到收藏夹

Article Microbiology

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Alexander E. Gorbalenya et al.

NATURE MICROBIOLOGY (2020)

添加到收藏夹

Review Rheumatology

Vasculitis Following Influenza Vaccination: A Review of the Literature

Toru Watanabe

CURRENT RHEUMATOLOGY REVIEWS (2017)

添加到收藏夹

Review Immunology

Vasculitis as an adverse event following immunization - Systematic literature review

Caterina Bonetto et al.

VACCINE (2016)

添加到收藏夹

Article Urology & Nephrology

Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis

Lisa S. Jeffs et al.

NEPHROLOGY (2015)

添加到收藏夹

Article Urology & Nephrology

Antineutrophil Cytoplasmic Antibody Vasculitis Associated with Influenza Vaccination

Tanu Duggal et al.

AMERICAN JOURNAL OF NEPHROLOGY (2013)

添加到收藏夹

Article Urology & Nephrology

Prediction of ESRD in Pauci-immune Necrotizing Glomerulonephritis: Quantitative Histomorphometric Assessment and Serum Creatinine

Clara J. Day et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2010)

添加到收藏夹

Article Rheumatology

ANCA-Associated Vasculitis Following Influenza Vaccination Causal Association or Mere Coincidence?

Rainer Birck et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)

添加到收藏夹

Article Physiology

Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement

Z Rihova et al.

KIDNEY & BLOOD PRESSURE RESEARCH (2005)

添加到收藏夹

Article Urology & Nephrology

Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study

AD Booth et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.